Nanotechnology Offers Alternative Ways to Fight COVID-19 Pandemic with Antivirals

Share This Story, Choose Your Platform!

A flurry of recent papers highlights growing interest in approaches that employ nanomaterials as antiviral countermeasures. Compared with traditional small molecules or antibodies that inhibit viral replication or cellular entry, nanotechnology offers drug developers virus binders, cell-membrane decoys or viral-envelope inhibitors that may complement conventional antiviral therapies. With the help of an influx of funding spurred by the COVID-19 pandemic, some researchers hope that these materials could soon move towards clinical translation. Read more…